| Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net income | 17 | 112 | 156 | 143 |
|---|
| Loss from discontinued operations, net of income taxes | - | - | -22 | -29 |
|---|
| Income from continuing operations | - | - | 178 | 172 |
|---|
| Depreciation and amortization | 73 | 131 | 104 | 99 |
|---|
| Goodwill, Impairment Loss | - | - | - | 37 |
|---|
| Impairment, Long-Lived Asset, Held-for-Use | - | 0 | 2 | 6 |
|---|
| Incremental Charges, Biological Assets And Inventory | 66 | 41 | - | - |
|---|
| Net gain on sale of assets | - | 12 | 54 | 3 |
|---|
| Gain (Loss) on Disposition of Stock in Subsidiary | - | - | - | 76 |
|---|
| Unrealized Gain (Loss) on Investments | 4 | -7 | - | 12 |
|---|
| Stock-based compensation expense | 1 | 5 | 6 | 8 |
|---|
| Equity method earnings | 48 | 7 | 15 | 8 |
|---|
| Amortization of Debt Issuance Costs and Discounts | 3 | 6 | 6 | 8 |
|---|
| Deferred tax benefit | -23 | -35 | -13 | -18 |
|---|
| Pension and other postretirement benefit plan expense | 3 | 3 | 8 | 5 |
|---|
| Dividends Received | 12 | 10 | 9 | 7 |
|---|
| Other | -2 | 0 | -4 | 0 |
|---|
| Receivables, net of allowances | 21 | -20 | -59 | 21 |
|---|
| Inventories | 57 | 38 | -21 | 71 |
|---|
| Prepaids, other current assets and other assets | - | - | 28 | 0 |
|---|
| Accounts payable, accrued liabilities and other liabilities | -33 | -4 | 13 | 131 |
|---|
| Net Cash Provided by (Used in) Operating Activities, Continuing Operations | - | - | 299 | 263 |
|---|
| Sales of assets | 26 | 37 | 84 | 5 |
|---|
| Capital expenditures | 65 | 98 | 78 | 82 |
|---|
| Proceeds from Sales of Business, Affiliate and Productive Assets | - | - | - | 118 |
|---|
| Proceeds from sale of business, net of transaction costs | -104 | 5 | 1 | 1 |
|---|
| Insurance proceeds | 10 | 2 | 1 | 1 |
|---|
| Purchases of investments | 1 | 0 | 1 | 0 |
|---|
| (Purchases) sales of unconsolidated affiliates | 2 | 3 | -1 | 2 |
|---|
| Other | -0 | -1 | -0 | 2 |
|---|
| Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total | - | - | 5 | 36 |
|---|
| Proceeds from Issuance of Debt | 2,145 | 1,293 | 1,408 | 1,517 |
|---|
| Repayments on borrowings and overdrafts | - | 1,411 | 1,576 | 1,696 |
|---|
| Payment of debt issuance costs | 22 | 0 | 0 | - |
|---|
| Dividends paid to shareholders | 17 | 30 | 30 | 31 |
|---|
| Dividends paid to noncontrolling interests | 22 | 22 | 29 | 27 |
|---|
| Other noncontrolling interest activity, net | - | - | -1 | -0 |
|---|
| Payments of contingent consideration | 5 | 3 | 2 | 2 |
|---|
| Proceeds from Issuance Initial Public Offering | 399 | - | - | - |
|---|
| Net cash used in financing activities - continuing operations | -1 | -173 | -230 | -238 |
|---|
| Effect of foreign currency exchange rate changes on cash | -8 | -21 | 5 | -15 |
|---|
| Cash Provided by (Used in) Operating Activities, Discontinued Operations | - | - | -23 | 23 |
|---|
| Net cash used in investing activities - discontinued operations | - | - | -8 | -13 |
|---|
| Cash provided by (used in) discontinued operations, net | - | - | -31 | 9 |
|---|
| Increase (decrease) in cash and cash equivalents | 90 | -22 | 48 | 55 |
|---|
| Income tax payments, net of refunds | 27 | 50 | 64 | 78 |
|---|
| Interest payments on borrowings | 27 | 54 | 82 | 67 |
|---|
| Accrued property, plant and equipment | 5 | 0 | 1 | 3 |
|---|